447 related articles for article (PubMed ID: 12610867)
1. [Current status of the neo-adjuvant and adjuvant therapy for the resectable non-small cell lung cancer].
Yamaguchi M; Fukuyama Y; Ichinose Y
Gan To Kagaku Ryoho; 2003 Feb; 30(2):203-8. PubMed ID: 12610867
[TBL] [Abstract][Full Text] [Related]
2. [Recent changes in the management of advanced non-small cell lung cancer].
Kodama N; Kawahara M; Furuse K
Gan To Kagaku Ryoho; 1994 Nov; 21(15):2564-70. PubMed ID: 7979414
[TBL] [Abstract][Full Text] [Related]
3. [Postoperative adjuvant treatment for non-small cell lung cancer].
Ichinose Y
Gan To Kagaku Ryoho; 2002 Dec; 29(13):2470-4. PubMed ID: 12506468
[TBL] [Abstract][Full Text] [Related]
4. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline.
Pisters KM; Evans WK; Azzoli CG; Kris MG; Smith CA; Desch CE; Somerfield MR; Brouwers MC; Darling G; Ellis PM; Gaspar LE; Pass HI; Spigel DR; Strawn JR; Ung YC; Shepherd FA; ;
J Clin Oncol; 2007 Dec; 25(34):5506-18. PubMed ID: 17954710
[TBL] [Abstract][Full Text] [Related]
5. Patient subsets benefiting from adjuvant therapy following surgical resection of non-small cell lung cancer.
Johnson BE; Rabin MS
Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5022s-5026s. PubMed ID: 16000607
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant chemotherapy and radiotherapy in non-small cell lung cancer.
Erman M; Moretti L; Soria JC; Le Chevalier T; Van Houtte P
Semin Radiat Oncol; 2004 Oct; 14(4):315-21. PubMed ID: 15558506
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy and radiotherapy in the treatment of resectable non-small-cell lung cancer.
Bernstein ED; Herbert SM; Hanna NH
Ann Surg Oncol; 2006 Mar; 13(3):291-301. PubMed ID: 16450219
[TBL] [Abstract][Full Text] [Related]
8. [Induction therapy for non-small cell lung cancer].
Matsumara A; Mori T
Gan To Kagaku Ryoho; 2001 Nov; 28(12):1826-32. PubMed ID: 11729474
[TBL] [Abstract][Full Text] [Related]
9. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.
van Meerbeeck JP; Kramer GW; Van Schil PE; Legrand C; Smit EF; Schramel F; Tjan-Heijnen VC; Biesma B; Debruyne C; van Zandwijk N; Splinter TA; Giaccone G;
J Natl Cancer Inst; 2007 Mar; 99(6):442-50. PubMed ID: 17374834
[TBL] [Abstract][Full Text] [Related]
10. [Non-small cell lung cancer (NSCLC): the evolution of neo-adjuvant chemotherapy in the last 15 years].
Santo A; Genestreti G; Fiorio E; Terzi A; Lonardoni A; Calabrò F; Campaldini B; Colaluca P; Molino A; Cetto GL
Recenti Prog Med; 2006 Apr; 97(4):211-8. PubMed ID: 16729492
[TBL] [Abstract][Full Text] [Related]
11. [Assessment of a phase III trial of adjuvant chemotherapy in resected lung cancer: an imbalance of surgical results among cooperative institutions].
Ohta M; Hara N
Gan To Kagaku Ryoho; 1991 Jul; 18(9):1511-5. PubMed ID: 1649582
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant chemotherapy in resected non-small cell lung cancer.
Cangiano R
Rays; 2004; 29(4):435-7. PubMed ID: 15852732
[TBL] [Abstract][Full Text] [Related]
13. [Multimodal treatment of non small cell lung cancer].
Stoelben E; Digel W; Henke M; Passlick B
Zentralbl Chir; 2006 Apr; 131(2):110-4. PubMed ID: 16612776
[TBL] [Abstract][Full Text] [Related]
14. [Management of resectable non-small cell lung cancer. Guidelines of clinical practice made by the European Lung Cancer Working Party].
European Lung Cancer Working Party
Rev Med Brux; 2006; 27(1):29-38. PubMed ID: 16608009
[TBL] [Abstract][Full Text] [Related]
15. Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: results of a meta-analysis of the literature.
Berghmans T; Paesmans M; Meert AP; Mascaux C; Lothaire P; Lafitte JJ; Sculier JP
Lung Cancer; 2005 Jul; 49(1):13-23. PubMed ID: 15949586
[TBL] [Abstract][Full Text] [Related]
16. [Early stages of non small cell lung cancer (I. II. IIIA). What is the best therapeutic strategy?].
Riquet M; Berna P
Rev Mal Respir; 2006 Nov; 23(5 Pt 3):16S36-16S42. PubMed ID: 17268334
[TBL] [Abstract][Full Text] [Related]
17. Comparison of neoadjuvant cisplatin-based chemotherapy versus radiochemotherapy followed by resection for stage III (N2) NSCLC.
Pezzetta E; Stupp R; Zouhair A; Guillou L; Taffé P; von Briel C; Krueger T; Ris HB
Eur J Cardiothorac Surg; 2005 Jun; 27(6):1092-8. PubMed ID: 15896624
[TBL] [Abstract][Full Text] [Related]
18. [Adjuvant chemotherapy for non-small cell lung cancer].
Otake Y; Tanaka F; Wada H; Hitomi S
Gan To Kagaku Ryoho; 1997 Aug; 24(10):1245-51. PubMed ID: 9279343
[TBL] [Abstract][Full Text] [Related]
19. Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: the adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial.
Douillard JY; Rosell R; De Lena M; Riggi M; Hurteloup P; Mahe MA;
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):695-701. PubMed ID: 18439766
[TBL] [Abstract][Full Text] [Related]
20. Induction chemoradiation therapy followed by surgical resection for non-small cell lung cancer (NSCLC) invading the thoracic inlet.
Fischer S; Darling G; Pierre AF; Sun A; Leighl N; Waddell TK; Keshavjee S; de Perrot M
Eur J Cardiothorac Surg; 2008 Jun; 33(6):1129-34. PubMed ID: 18407511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
